TUBE, TRACHEAL

The contract solicits a single package of ten infant endotracheal tubes without a cuff, specified as Murphy-style with a 3.5 mm internal diameter, open end tip, single shaft eye, and a 15 mm connector featuring size markings. The tubes are equipped with a Luer taper inflation valve and are constructed from rigid polyvinyl chloride (PVC) for secure oral or nasal intubation. The item is identified by NSN 6515-01-233-7556 and must meet strict medical device standards, including FDA 510(k) clearance, establishment registration, product listing, and adherence to current Good Manufacturing Practices (cGMP). The product must have a shelf life of 60 months from manufacture, with no more than nine months elapsed at the time of delivery to the government, and packaging must fully comply with MIL-STD-2073-1E for preservation and packaging, as well as the Medical Marking Standard No. 1, which supersedes MIL-STD-129 for all medical acquisitions except those involving radioactive materials. All units must be sealed in protective individual containers and packed in commercial shipping containers suitable for international delivery via common carriers to destinations including Kunsan Air Base, South Korea, and APO, AP 96264-2022. The solicitation, issued under SPE2DS-26-T-312F by the Department of Defense’s Medical Supply Chain under DLA Troop Support, requires full compliance with Federal Acquisition Regulation clauses, including safeguards for contractor information systems, accelerated payments to small business subcontractors, prohibition of confidentiality agreements, and adherence to NIST SP 800-171 cybersecurity requirements. Delivery is mandated within five days of order receipt, with FOB destination terms, and invoicing must be submitted exclusively through Wide Area WorkFlow. The contract incorporates provisions for inspection and acceptance at the destination, with responsibility assigned to the government, and imposes labeling requirements for hazardous materials under DFARS clause 252.223-7001. Offerors must be registered in the System for Award Management, possess a Unique Entity ID, and provide accurate size and socioeconomic status certifications, particularly if bidding as a small business or joint venture. All proposals must be submitted electronically via the DLA Internet Bid Board System by the August 11, 2026 deadline, and include technical documentation, FDA certification, labeling samples